| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/18/2023 |
4
| McWherter Charles (President of R&D) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 21,746 shares
@ $11.4669, valued at
$249.4k
Exercised 10,404 options to buy
@ $5, valued at
$52k
Exercised 708 options to buy
@ $5, valued at
$3.5k
Exercised 236 options to buy
@ $5, valued at
$1.2k
Exercised 3,892 options to buy
@ $5, valued at
$19.5k
Exercised 6,506 options to buy
@ $5, valued at
$32.5k
|
|
| 08/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
4
| Menold Daniel (Vice President, Finance) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold shares
@ $11.9158, valued at
$0
Sold shares
@ $12.1293, valued at
$0
Exercised 8,500 options to buy
@ $1.06, valued at
$9k
Exercised 7,000 options to buy
@ $10, valued at
$70k
|
|
| 08/16/2023 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $11.9101, valued at
$59.6k
Exercised 5,000 options to buy
@ $2.94, valued at
$14.7k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
4
| Menold Daniel (Vice President, Finance) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 20,945 shares
@ $12.3535, valued at
$258.7k
Exercised 14,459 options to buy
@ $5, valued at
$72.3k
Exercised 6,486 rights
@ $5, valued at
$32.4k
|
|
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/10/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $10.05, valued at
$50.3k
Exercised 5,000 options to buy
@ $2.94, valued at
$14.7k
|
|
| 06/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/19/2023 |
4
| McWherter Charles (President of R&D) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 21,749 shares
@ $9.0757, valued at
$197.4k
Exercised 10,407 options to buy
@ $5, valued at
$52k
Exercised 708 options to buy
@ $5, valued at
$3.5k
Exercised 236 options to buy
@ $5, valued at
$1.2k
Exercised 3,892 options to buy
@ $5, valued at
$19.5k
Exercised 6,506 options to buy
@ $5, valued at
$32.5k
|
|
|